Tsai F Y, Berberian B, Matovich V, Lavin M, Alfieri K
University of Missouri, Kansas City School of Medicine 64108.
AJNR Am J Neuroradiol. 1994 Nov;15(10):1823-9.
To report three patients, each of whom had acute rethrombosis of a reopened middle cerebral artery after urokinase treatment for proximal stenosis (percutaneous transluminal angioplasty of the stenosis was performed adjunctive to the thrombolytic treatment to preserve the success of the thrombolysis), and a fourth patient who had percutaneous transluminal angioplasty right after the completion of thrombolysis and had no rethrombosis despite a partial dilatation of the severe stenosis.
Thrombolytic treatment was carried out by a coaxial technique with a Tracker 18 catheter through a 5-F angiographic catheter; 80,000 U in 5 mL of urokinase were intermittently injected every 15 minutes after an initial dose of 250,000 U. All patients were given 3000 U of heparin with a booster dose of 1000 U every hour. Angioplasty was performed with a Stealth catheter balloon, 2 to 3 mm x 1.5 cm.
Three patients recovered without hemorrhage after percutaneous transluminal angioplasty and thrombolytic treatment. Percutaneous transluminal angioplasty was unsuccessful in one patient because of the inability to pass a 2-mm Stealth balloon catheter, and the result was a second rethrombosis. This patient had a poor recovery.
Acute thrombosis of the middle cerebral artery may be associated with severe proximal stenosis. Rethrombosis may occur even after complete thrombolysis. Percutaneous transluminal angioplasty may be safely performed to prevent rethrombosis.
报告3例患者,他们在接受尿激酶治疗近端狭窄后(在溶栓治疗的同时进行经皮腔内血管成形术以维持溶栓成功),大脑中动脉再通后发生急性再血栓形成,以及第4例患者,其在溶栓完成后立即进行经皮腔内血管成形术,尽管严重狭窄仅部分扩张,但未发生再血栓形成。
采用同轴技术,通过5F血管造影导管使用Tracker 18导管进行溶栓治疗;在初始剂量250,000 U后,每15分钟间歇注射5 mL含80,000 U尿激酶的溶液。所有患者均给予3000 U肝素,每小时追加1000 U。使用2至3 mm×1.5 cm的Stealth导管球囊进行血管成形术。
3例患者在经皮腔内血管成形术和溶栓治疗后未发生出血而康复。1例患者因无法通过2 mm的Stealth球囊导管导致经皮腔内血管成形术失败,结果发生第二次再血栓形成。该患者恢复不佳。
大脑中动脉急性血栓形成可能与严重的近端狭窄有关。即使在完全溶栓后也可能发生再血栓形成。经皮腔内血管成形术可安全地用于预防再血栓形成。